Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
By Samuel A. Wells, Sylvia L. Asa, H. Dralle, R. Elisei, Douglas B. Evans, R. Gagel, Nancy Y. Lee, A. Machens, J. Moley, F. Pacini and 9 more. Thyroid, 2015
2,039 citations recorded by the source corpus.
Introduction: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. Methods: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document. Results: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC. Conclusions: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/94012842d014eca36fffd015af89abe798b54b67
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2019, methodology): “Multiple imaging modalities should be used to identify locoregional and/or distant metastases [IV, B] [142, 143].”